- Home
- NQP vs EBS Comparison
NQP vs EBS Comparison
Compare NQP & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NQP
- EBS
- Stock Information
- Founded
- NQP 1990
- EBS 1998
- Country
- NQP United States
- EBS United States
- Employees
- NQP N/A
- EBS 900
- Industry
- NQP Trusts Except Educational Religious and Charitable
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- NQP Finance
- EBS Health Care
- Exchange
- NQP Nasdaq
- EBS Nasdaq
- Market Cap
- NQP 412.0M
- EBS 353.9M
- IPO Year
- NQP N/A
- EBS 2006
- Fundamental
- Price
- NQP $11.21
- EBS $6.39
- Analyst Decision
- NQP
- EBS Strong Buy
- Analyst Count
- NQP 0
- EBS 3
- Target Price
- NQP N/A
- EBS $14.33
- AVG Volume (30 Days)
- NQP 58.4K
- EBS 1.3M
- Earning Date
- NQP 01-01-0001
- EBS 08-05-2025
- Dividend Yield
- NQP 3.21%
- EBS N/A
- EPS Growth
- NQP N/A
- EBS N/A
- EPS
- NQP N/A
- EBS N/A
- Revenue
- NQP N/A
- EBS $965,400,000.00
- Revenue This Year
- NQP N/A
- EBS N/A
- Revenue Next Year
- NQP N/A
- EBS $18.88
- P/E Ratio
- NQP N/A
- EBS N/A
- Revenue Growth
- NQP N/A
- EBS N/A
- 52 Week Low
- NQP $9.65
- EBS $4.02
- 52 Week High
- NQP $11.89
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- NQP 51.37
- EBS 60.32
- Support Level
- NQP $11.03
- EBS $6.53
- Resistance Level
- NQP $11.13
- EBS $6.98
- Average True Range (ATR)
- NQP 0.07
- EBS 0.35
- MACD
- NQP 0.01
- EBS 0.01
- Stochastic Oscillator
- NQP 66.67
- EBS 84.04
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.